methanesulfonyl fluoride has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braglia, E; Fariello, RG; Moss, DE; Pericle, F; Sahlmann, J; Sumaya, I | 1 |
| Berlanga, P; Hagan, MM; Ishida, C; Moss, DE; Sandoval, H | 1 |
2 trial(s) available for methanesulfonyl fluoride and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Erythrocyte Membrane; Female; Half-Life; Humans; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Sulfones | 2013 |
Methanesulfonyl fluoride (MSF): a double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type.
Topics: Acetylcholinesterase; Administration, Oral; Adult; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Palliative Care; Sulfones; Treatment Outcome | 1999 |